InvestorsHub Logo
Followers 10
Posts 1265
Boards Moderated 0
Alias Born 11/10/2015

Re: Bourbon_on_my_cornflakes post# 20195

Monday, 05/15/2017 6:44:21 AM

Monday, May 15, 2017 6:44:21 AM

Post# of 108192
The ADXS approach is not comparable in any reasonable way to CAR-T cell therapy. It is not useful to compare them, as they're approaching totally different disease settings with totally different strategies.

The striking efficacy has gotten CAR-T cell therapy the much-deserved attention it's gotten. AXAL has not (yet) demonstrated something so striking.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ADXS News